These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

66 related articles for article (PubMed ID: 11178406)

  • 1. Potency Testing of Erysipelas Vaccines in Mice. ELISA vs. Challenge.
    Beckmann R; Cussler K
    ALTEX; 1994; 11(5):39-45. PubMed ID: 11178406
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Batch potency testing of inactivated erysipelas vaccines by ELISA--development, validation and implementation.
    Rosskopf-Streicher U; Johannes S; Gyra H; Beckmann R; Cussler K
    Dev Biol (Basel); 2002; 111():153-8. PubMed ID: 12678235
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Collaborative study for the establishment of erysipelas ELISA coating antigen. European Biological Reference Preparation batch no. 1.
    Cussler K; Rosskopf-Streicher U; Volkers P; Milne C
    Pharmeuropa Spec Issue Biol; 2001 Aug; 2001(1):75-88. PubMed ID: 11705102
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Potency Testing of Swine Erysipelas Vaccines by Serology Results of a Pre-validation Study.
    Rosskopf-Streicher U; Johannes S; Wilhelm M; Gyra H; Cussler K
    ALTEX; 1999; 16(3):123-128. PubMed ID: 11107318
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [100 years of erysipelas prophylaxis: significance and reduction of animal experiments].
    Cussler K; Balks E
    ALTEX; 2001; 18(1):29-33. PubMed ID: 11248847
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Investigation about development of alternative efficacy verifications of swine erysipelas vaccines.
    Gyra H; Volmer R; Hausleithner D
    ALTEX; 1994; 11(5):46-54. PubMed ID: 11178407
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Use of in vitro Vero cell assay and ELISA in the United States potency test of vaccines containing adsorbed diphtheria and tetanus toxoids.
    Gupta RK; Siber GR
    Dev Biol Stand; 1996; 86():207-15. PubMed ID: 8785950
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cross protection in mice and swine immunized with live erysipelas vaccine to challenge exposure with strains of Erysipelothrix rhusiopathiae of various serotypes.
    Takahashi T; Takagi M; Sawada T; Seto K
    Am J Vet Res; 1984 Oct; 45(10):2115-8. PubMed ID: 6497110
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pasteurella multocida toxin type D serological assay as an alternative to the toxin neutralisation lethality test in mice.
    Finco-Kent DL; Galvin JE; Suiter BT; Huether MJ
    Biologicals; 2001 Mar; 29(1):7-10. PubMed ID: 11482887
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Humane endpoints in the efficacy testing of swine erysipelas vaccines.
    Johannes S; Hartinger J; Hendriksen CF; Morton DB; Cussler K
    ALTEX; 2003; 20(1):11-5. PubMed ID: 12579350
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Development of pertussis serological potency test. Serological assessment of antibody response induced by whole cell vaccine as an alternative to mouse protection in an intracerebral challenge model.
    van der Ark A; van Straaten-van de Kappelle I; Akkermans A; Hendriksen C; van de Donk H
    Biologicals; 1994 Sep; 22(3):233-42. PubMed ID: 7811457
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cross protection of mice and swine inoculated with culture filtrate of attenuated Erysipelothrix rhusiopathiae and challenge exposed to strains of various serovars.
    Sawada T; Takahashi T
    Am J Vet Res; 1987 Feb; 48(2):239-42. PubMed ID: 3826862
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Detection of Erysipelothrix rhusiopathiae specific antibodies in the serum of experimentally-infected swine by ELISA and immunoblotting].
    Dahms H; Schilow WF; Hagemann G
    Arch Exp Veterinarmed; 1989 Nov; 43(6):907-16. PubMed ID: 2619491
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Use of ELISA for in vitro potency test of rabies vaccines for animal use.
    Gamoh K; Senda M; Itoh O; Muramatsu M; Hirayama N; Koike R; Endoh YS; Minamoto N
    Biologicals; 1996 Jun; 24(2):95-101. PubMed ID: 8889055
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Determination of protective erysipelas antibodies in pig and mouse sera as possible alternatives to the animal challenge models currently used for potency tests.
    Beckmann R; Gyra H; Cussler K
    Dev Biol Stand; 1996; 86():326. PubMed ID: 8785966
    [No Abstract]   [Full Text] [Related]  

  • 16. Cross protection of mice and swine given live-organism vaccine against challenge exposure with strains of Erysipelothrix rhusiopathiae representing ten serovars.
    Sawada T; Takahashi T
    Am J Vet Res; 1987 Jan; 48(1):81-4. PubMed ID: 3826847
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Development and evaluation of alternative testing methods for the in vivo NIH potency test used for the quality control of inactivated rabies vaccines.
    Rooijakkers E; Groen J; Uittenbogarrd J; van Herwijnen J; Osterhaus A
    Dev Biol Stand; 1996; 86():137-45. PubMed ID: 8785943
    [TBL] [Abstract][Full Text] [Related]  

  • 18. An in vitro alternative to the mouse neutralisation assay for potency testing of betatoxoid containing Clostridium, perfringens type B and type C vaccines for veterinary use.
    Ebert E; Kusch M; Öppling V; Werner E; Cussler K
    ALTEX; 1996; 13(2):68-75. PubMed ID: 11178445
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Susceptibility of vaccinated swine and mice to generalized infection with specific serotypes of Erysipelothrix rhusiopathiae.
    Wood RL; Booth GD; Cutlip RC
    Am J Vet Res; 1981 Apr; 42(4):608-14. PubMed ID: 6174056
    [TBL] [Abstract][Full Text] [Related]  

  • 20. General information about the validation of serological method (ELISA) for the batch potency testing erysipelas vaccines.
    Altern Lab Anim; 2002; 30(5):486-7. PubMed ID: 12434771
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.